NLS Pharmaceutics (NLSP) Short Interest Ratio & Short Volume → “Retirement Secret” Showed 995% Gain Last Time We Shared It (From Stansberry Research) (Ad) Free NLSP Stock Alerts $0.13 +0.01 (+6.80%) (As of 10:55 AM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media NLS Pharmaceutics Short Interest DataCurrent Short Volume75,100 sharesPrevious Short Volume335,800 sharesChange Vs. Previous Month-77.64%Dollar Volume Sold Short$10,626.65Short Interest Ratio / Days to Cover0.1Last Record DateApril 15, 2024Float Size21,840,000 sharesShort Percent of Float0.34%Today's Trading Volume11,552 sharesAverage Trading Volume464,680 sharesToday's Volume Vs. Average2% Short Selling NLS Pharmaceutics ? Sign up to receive the latest short interest report for NLS Pharmaceutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatNLSP Short Interest Over TimeNLSP Days to Cover Over TimeNLSP Percentage of Float Shorted Over Time Ad Chaikin AnalyticsWall Street Legend Issues New NVDA WarningLegendary Stockpicker: "Buy this A.I. stock NOW" His award-winning system pinpointed NVDA and META before both stocks doubled. Now it's flashing "BUY" on this under-the-radar A.I. stock.Click here for the stock details NLS Pharmaceutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/202475,100 shares $10,626.65 -77.6%0.3%0.1 $0.14 3/31/2024335,800 shares $60,444.00 +854.0%1.5%0.6 $0.18 3/15/202435,200 shares $10,876.80 -43.0%0.2%0.1 $0.31 2/29/202461,800 shares $23,904.24 -22.4%0.3%0.8 $0.39 2/15/202479,600 shares $35,820.00 -15.4%0.3%0.2 $0.45 1/31/202494,100 shares $43,286.00 -22.4%0.4%0.2 $0.46 Get the Latest News and Ratings for NLSP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for NLS Pharmaceutics and its competitors with MarketBeat's FREE daily newsletter. 1/15/2024121,200 shares $63,024.00 -19.7%0.5%0.2 $0.52 12/31/2023150,900 shares $89,015.91 +32.5%0.7%0.3 $0.59 12/15/2023113,900 shares $54,672.00 -15.0%0.5%0.2 $0.48 11/30/2023134,000 shares $58,785.80 +29.0%0.7%0.2 $0.44 11/15/2023103,900 shares $50,713.59 -37.2%0.5%0.7 $0.49 10/31/2023165,400 shares $109,164.00 -24.0%0.8%1.6 $0.66 10/15/2023217,700 shares $182,693.84 +40.2%1.1%1.8 $0.84 9/30/2023155,300 shares $108,710.00 -2.1%0.8%1.7 $0.70 9/15/2023158,600 shares $131,526.98 +33.3%0.8%0.9 $0.83 8/31/2023119,000 shares $121,380.00 +38.7%0.6%0.7 $1.02 8/15/202385,800 shares $70,347.42 -23.5%0.4%0.6 $0.82 7/31/2023112,100 shares $104,006.38 +95.3%0.6%0.8 $0.93 7/15/202357,400 shares $51,591.12 +48.7%0.3%0.5 $0.90 6/30/202338,600 shares $42,460.00 -43.4%0.2%0.3 $1.10 6/15/202368,200 shares $66,154.00 -31.7%0.3%1.6 $0.97 5/31/202399,900 shares $102,897.00 -8.9%0.5%2.4 $1.03 5/15/2023109,600 shares $117,820.00 -6.4%0.5%2.2 $1.08 4/30/2023117,100 shares $155,743.00 -0.4%0.5%2.3 $1.33 4/15/2023117,600 shares $183,456.00 -7.2%0.6%2.3 $1.56 3/31/2023126,700 shares $192,584.00 +44.3%0.6%1.8 $1.52 3/15/202387,800 shares $130,822.00 -38.8%0.4%1 $1.49 2/28/2023143,500 shares $205,205.00 +5.6%0.7%1.5 $1.43 2/15/2023135,900 shares $186,183.00 +13.4%0.7%1.1 $1.37 1/31/2023119,800 shares $155,740.00 -22.3%0.6%0.8 $1.30 1/15/2023154,100 shares $265,052.00 -23.2%0.7%0.4 $1.72 12/30/2022200,700 shares $258,903.00 +32.2%0.9%0.5 $1.29 12/15/2022151,800 shares $157,872.00 +26.6%0.7%0.3 $1.04 11/30/2022119,900 shares $99,517.00 -23.3%1.0%0.2 $0.83 11/15/2022156,300 shares $78,915.87 +63.0%1.3%0.3 $0.50 10/31/202295,900 shares $50,107.75 +15.7%0.8%0.1 $0.52 10/15/202282,900 shares $43,108.00 -57.2%0.7%0.2 $0.52 9/30/2022193,500 shares $119,970.00 -27.6%1.4%0.4 $0.62 9/15/2022267,100 shares $226,500.80 +80.6%1.9%0.6 $0.85 8/31/2022147,900 shares $73,195.71 -27.5%1.1%0.4 $0.49World’s biggest multibillionaire investor is buying THIS by the ton [picture] (Ad)Don't Buy Bullion or Mining Stocks. Do THIS Instead As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea.Click here to find out what to do. NLSP Short Interest - Frequently Asked Questions What is NLS Pharmaceutics' current short interest? Short interest is the volume of NLS Pharmaceutics shares that have been sold short but have not yet been covered or closed out. As of March 31st, traders have sold 335,800 shares of NLSP short. 1.54% of NLS Pharmaceutics' shares are currently sold short. Learn More on NLS Pharmaceutics' current short interest. What is a good short interest ratio for NLS Pharmaceutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. NLSP shares currently have a short interest ratio of 1.0. Learn More on NLS Pharmaceutics's short interest ratio. What is a good short interest percentage for NLS Pharmaceutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.54% of NLS Pharmaceutics' floating shares are currently sold short. Is NLS Pharmaceutics' short interest increasing or decreasing? NLS Pharmaceutics saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 335,800 shares, an increase of 854.0% from the previous total of 35,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is NLS Pharmaceutics' float size? NLS Pharmaceutics currently has issued a total of 0 shares. Some of NLS Pharmaceutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. NLS Pharmaceutics currently has a public float of 21,840,000 shares. How does NLS Pharmaceutics' short interest compare to its competitors? 1.54% of NLS Pharmaceutics' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to NLS Pharmaceutics: Context Therapeutics Inc. (0.08%), Grifols, S.A. (2.32%), LAVA Therapeutics (1.50%), Mainz Biomed (2.34%), Pharvaris (0.10%), Procaps Group S.A. (0.03%), Qilian International Holding Group Limited (0.07%), American Oncology Network, Inc. (1.02%), Concord Medical Services Holdings Limited (0.06%), Exicure, Inc. (2.40%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks. What does it mean to sell short NLS Pharmaceutics stock? Short selling NLSP is an investing strategy that aims to generate trading profit from NLS Pharmaceutics as its price is falling. NLSP shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against NLS Pharmaceutics? A short squeeze for NLS Pharmaceutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of NLSP, which in turn drives the price of the stock up even further. How often is NLS Pharmaceutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NLSP, twice per month. The most recent reporting period available is March, 31 2024. More Short Interest Resources from MarketBeat Related Companies: CNTX Short Squeeze GRFS Short Squeeze LVTX Short Squeeze MYNZ Short Squeeze PHVS Short Squeeze TLSA Short Squeeze ATNFW Short Squeeze ACONW Short Squeeze AIMDW Short Squeeze DRTSW Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:NLSP) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarHe Is Giving Away BitcoinCrypto Swap Profits“The Biggest Bubble of All Time” – Here’s What to Do.Chaikin AnalyticsYour Money is Not SafeAmerican Alternativetop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders Agency